Agilent - A Company Current Liabilities

Corporate company logo of Agilent Technologies (A)

Agilent Technologies (A) is recognized as a flawless supplier of precision scientific instruments. High barriers to entry in this consolidated sector protect the business from new entrants. Cost optimization is achieved through external module assembly and service outsourcing. The current liabilities metric reflects liquidity dynamics, with the parameter reaching 0.08, which determines the company's current degree of financial autonomy.

A agilent.com Short-Term Debt Volume (07/04/2022 - 10/30/2026)

Metric breakdowns and analytics for Agilent Corp (A)

- current quotes and average value forecast:
Price Chart Agilent|A - Price Target Chart
- issuer market value details:
Market Valuation Agilent Technologies|A - Total Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Agilent|A - Book Valuation of Business|Market Capitalization to Book Value Ratio agilent.com|A - Company Total Asset Base
- debt and liquidity details:
Debt to Equity Agilent Technologies|A - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Agilent Technologies|A - Company Aggregate Debts|Debts to Book Capitalization Agilent Technologies|A - Long-Term Indebtedness|Company Short-Term Debts Agilent|Quick Liquidity agilent.com
- earnings and multiples data:
A - Company Net Income
Analysis of all company metrics:Agilent (A)
Mass-produced product of Agilent Corp

Short-term debt records the obligations of Agilent Technologies (A) with maturities of up to one year, determining the issuer's current liquidity. A reduction in this metric minimizes the risk of cash flow gaps, as confirmed by short-term liabilities. The current value of 0.08 serves as an indicator of financial stability. Debt control allows the company to effectively finance the transition to a service-based laboratory maintenance model. Loan optimization accelerates capital turnover within the high-margin consumables segment.

Analysis of competing companies

DGX - Company Short-Term Debt|ILMN: Company Short-Term Debt|EXAS (Cologuard) - Company Current Liabilities|Short-Term Debt Revvity Corp (RVTY)|Company Short-Term Debt Bio-Rad Laboratories|anbio.com (NNNN) - Short-Term Debt Volume|Company Short-Term Debts SHC|Short-Term Debt Volume Quidel Corporation|Company Short-Term Debt OPKO Corp OPK|Short-Term Debt Volume CareDx (CDNA)|Maravai LifeSciences - Company Short-Term Debts|FLGT - Company Short-Term Debts|LAB: Company Short-Term Debts|Short-Term Indebtedness Cytek Biosciences Inc CTKB|OSUR (OraSure Technologies Inc) - Company Short-Term Debts|Exagen Diagnostics (XGN) - Short-Term Debt Volume|Company Short-Term Debt MDxHealth SA (MDXH)|Company Short-Term Debt LUCD (luciddx.com)|Company Short-Term Debts PRE (Prenetics)|Insight Molecular Diagnostics, Inc. (IMDX) - Short-Term Debt|TRIB - Company Short-Term Debt|PRPH (ProPhase Labs Corp) - Company Short-Term Indebtedness|AIMD (Ainos, Inc.) - Company Current Liabilities|CODX: Amount of Current Liabilities|Company Current Liabilities HSCS|BMRA: Company Short-Term Loans and Borrowings|Company Current Liabilities CDIO (Cardio Diagnostics)|Amount of Current Liabilities VRAX|Company Short-Term Debts BJDX (Bluejay Diagnostics)|aspirawh.com (AWH) - Short-Term Debt|Accelerate Diagnostics, Inc. - Company Short-Term Debts|CENTOGENE N.V. (CNTG) - Company Current Liabilities|ENZ: Company Short-Term Debts|Fresh2 Group - Company Short-Term Loans and Borrowings|Company Short-Term Debt Genetic Technologies Ltd|Company Short-Term Indebtedness ME (23andme.com)|Company Short-Term Debt Psychemedics Corporation (PMD)